Omega Therapeutics Inc (OMGA)
2.08
-0.16
(-7.14%)
USD |
NASDAQ |
Jun 28, 16:00
2.01
-0.07
(-3.37%)
After-Hours: 20:00
Omega Therapeutics Cash from Operations (Quarterly): -11.80M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -11.80M |
| December 31, 2023 | -17.09M |
| September 30, 2023 | -23.04M |
| June 30, 2023 | -23.27M |
| March 31, 2023 | -28.11M |
| December 31, 2022 | -24.24M |
| September 30, 2022 | -24.84M |
| June 30, 2022 | -26.09M |
| March 31, 2022 | -23.35M |
| Date | Value |
|---|---|
| December 31, 2021 | -15.96M |
| September 30, 2021 | -16.50M |
| June 30, 2021 | -14.61M |
| March 31, 2021 | -10.55M |
| December 31, 2020 | -8.30M |
| September 30, 2020 | -6.641M |
| June 30, 2020 | -5.46M |
| March 31, 2020 | -5.732M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-28.11M
Minimum
Mar 2023
-5.46M
Maximum
Jun 2020
-16.80M
Average
-16.50M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Altimmune Inc | -16.36M |
| Macrogenics Inc | -45.64M |
| Viking Therapeutics Inc | -6.134M |
| vTv Therapeutics Inc | -7.335M |
| Rhythm Pharmaceuticals Inc | -40.74M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 4.465M |
| Cash from Financing (Quarterly) | -1.07M |
| Free Cash Flow | -78.61M |
| Free Cash Flow Per Share (Quarterly) | -0.2238 |
| Free Cash Flow to Equity (Quarterly) | -11.35M |
| Free Cash Flow Yield | -68.55% |